D-dimer Levels in Pregnant With COVID-19

Kanuni Sultan Suleyman Training and Research Hospital

Status: Completed

Conditions: COVID-19; D-dimer

Treatments: Other: Blood D-dimer assay

Study type: Observational

Funder types: Other

Identifiers

NCT04389554

MTalmac

Details and patient eligibility

About

D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.

Enrollment: 300 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pregnant women with COVID-19

Exclusion criteria

• Having a chronic disease that raises D-dimer levels

Trial design

300 participants in 2 patient groups

Control Group

Description:

Healthy pregnant women

Treatment:

Other: Blood D-dimer assay

Study Group

Description:

Pregnant women with COVID-19

Treatment:

Other: Blood D-dimer assay